Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REOPEN-AMI: Nitroprusside vs Adenosine in STEMI
NCT00590070Phase 3Completed
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Jan 2008
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of adenosine and sodium nitroprusside in myocardial infarction (MI), sponsored by Università Cattolica del Sacro Cuore. Primary endpoint: ST resolution. Started Jan 2008; status: completed.
02
Drugs
adenosinesodium nitroprusside
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00590070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00590070.